Abstract:BACKGROUND:Management of tumors has become more complex owing to tumor heterogeneity. Fewer studies have been performed on intra-tumor heterogeneity of endometrial cancer (EC) until now. Therefore, it is of great clinical value to explore the intra-tumor heterogeneity of EC based on clinical features and gene expression profiles.METHODS:A total of 1688 patients with EC were screened and 114 patients were finally selected, including specimens from 84 patients with primary EC without relapse (PE) and the paired metastases (P-M) specimens, as well as specimens from 30 patients with primary EC with relapse (RPE) and the paired relapsed EC (P-RE) specimens. Microarray and RNA-seq were used to detect gene expression of EC samples. Clinicopathological characteristics and molecular data were compared between PE and P-M groups and between RPE and P-RE groups to explore the intra-tumor heterogeneity of EC.RESULTS:The clinical intra-tumor spatial heterogeneity of pathological type, grade, ER status, and PR status between PE and P-M were 17.9%, 13.1%, 28.6%, and 28.6%, respectively. The clinical intra-tumor spatiotemporal heterogeneity of pathological type, grade, ER status, and PR status between RPE and P-RE were 16.7%, 33.3%, 25.0%, and 37.5%, respectively. Cluster analysis sorts EC samples based on progression type of lesion and their pathological type. There were differentially expressed genes between PE and P-M and between RPE and P-RE, of which gene ontology and Kyoto Encyclopedia of Genes and Genomes analysis were mainly enriched in cell proliferation, the p53 signaling pathway, etc. CONCLUSIONS:: Clinical and molecular data showed that there was spatiotemporal heterogeneity in intra-tumor of EC, which may add to the complexity of diagnosis and therapeutics for EC. Considering the intra-tumor heterogeneity, sequential chemotherapy and precision medicine may be a more suitable treatment plan for EC.

Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

Intra-tumor Heterogeneity for Endometrial Cancer and Its Clinical Significance

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications

Clinical implications of intratumor heterogeneity: challenges and opportunities

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Clinical management of breast cancer heterogeneity

Heterogeneity and treatment landscape of ovarian carcinoma

Cellular Heterogeneity and Molecular Evolution in Cancer

Proteomic and functional characterization of intra-tumor heterogeneity in human endometrial cancer

Molecular heterogeneity in breast cancer: State of the science and implications for patient care

Single-cell transcriptome profiles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identifies specific sensitive drugs

Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma

Breast cancer intratumour heterogeneity: current status and clinical implications

Heterogeneity Between Primary Colon Carcinoma and Paired Lymphatic and Hepatic Metastases.

Tumor Heterogeneity: The Challenge of Precision Medicine

Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications

A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics

Heterogeneity within molecular subtypes of breast cancer